LncSHRG promotes hepatocellular carcinoma progression by activating HES6

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Hepatocellular carcinoma (HCC) is a major global health concern with high mortality.
• The molecular mechanisms underlying HCC oncogenesis require further elucidation.

Purpose of the Study:

• To identify novel molecular players involved in hepatocellular carcinoma (HCC) progression.
• To elucidate the functional role and mechanism of lncSHRG in HCC.

Main Methods:

• Analysis of lncSHRG expression in human HCC samples.
• In vitro studies on liver cancer cell proliferation.
• In vivo tumor propagation studies in mice.
• Molecular mechanism studies involving SATB1 and HES6 promoter activity.

Main Results:

• lncSHRG was significantly upregulated in human HCC tissues.
• lncSHRG promoted liver cancer cell proliferation and tumor growth in vivo.
• lncSHRG facilitates HCC progression by recruiting SATB1 to the HES6 promoter, enhancing HES6 expression.
• HES6, a target gene, is highly expressed in HCC and correlates with poor prognosis.

Conclusions:

• lncSHRG plays a critical role in hepatocellular carcinoma (HCC) oncogenesis and progression.
• The lncSHRG/SATB1/HES6 axis represents a potential therapeutic target for HCC treatment.